Dr. Mary Louise Keohan

Dr. Mary Louise Keohan is a medical oncologist who specializes in a number of rare cancers, including mesothelioma.

In addition, Keohan focuses on gastrointestinal cancers that include soft-tissue sarcoma and Kaposi’s sarcoma at the Memorial Sloan Kettering Cancer Center in New York City. She has received research subsidies to delve deeper into disease causes and treatment.

Specialists in New York

New York is known as a hotbed of asbestos activity. In upstate New York there are natural asbestos deposits and large manufacturers that have been known to use asbestos. In the city, asbestos was widely used as the city was growing. In Long Island, asbestos was commonly used as the suburbs grew. Many New Yorkers were unwittingly exposed to asbestos.

If you were exposed to asbestos in New York, contact us today for more information about your treatment options. We can put you in contact with an experienced mesothelioma specialist, such as Keohan. Only a mesothelioma specialist can help you get the urgent treatment you need.

What are Keohan’s specialties

Keohan specializes in sarcoma, which begins in the body’s connective tissue that includes the tendons, fat, nerves and muscles. Her work also includes treatment and research into mesothelioma. She said she works with a group of physicians that include surgeons, radiation oncologists and pathologist to create individualized treatment plans. Keohan frequently uses chemotherapy with the treatment plans because it shrinks tumors before and after surgery.

What is Keohan’s background

Keohan graduated from Marymount College in New York with a bachelor’s degree in biology and completed her medical degree at St. George’s University School of Medicine, which is located in Grenada, West Indies. She continued her education at the University of Medicine and Dentistry of New Jersey. Keohan completed a fellowship at Columbia University College of Physicians and Surgeons.

In 1998, Keohan joined the faculty and staff at New York Presbyterian Hospital and assisted in developing clinical trials for sarcoma treatment. In 2004, she moved to Memorial Sloan Kettering, where she is continuing her research. Her clinical expertise includes gastrointestinal cancers, sarcomas and new therapies.

In her work to eradicate rare cancers, Keohan has been awarded research backing from several charitable organizations. This includes the Dorcas Casey Fund for Sarcoma, the Alan Rosenthal Research Fund and the Liddy Shriver Ewing’s Sarcoma Fund.

Keohan participates in several professional associations, including the Sarcoma Alliance for Research Through Collaboration (SARC), the American Society of Clinical Oncology and the Connective Tissue Sarcoma Society.